Extreme Networks, Inc. is rated a Strong Buy due to its shift to a high-margin SaaS-led business model combined with innovative AI tokenomics and strategic supply chain management. The company has pre-purchased $36 million in memory inventory, positioning it for improved gross margins through 2028. Growth in Platform ONE adoption and managed service provider channels indicates potential competitive gains against Hewlett Packard Enterprise, Juniper, and Cisco. Additionally, deferred revenue from bundled subscriptions supports accelerating recurring revenue and expanding operating margins beyond the current 17.4% non-GAAP level.
Extreme Networks' recent strategic moves provide context for readers interested in technology sector trends. For readers following technology stocks, here is Pluang's market snapshot as of Nov 07, 2026 02:41 WIB: Out of 150 priced US technology stocks, 85 rose and 65 fell today. Notable movers include ATOM at USD 3.00 with a 15.16% increase and a typical hold time of 18 days, WK at USD 73.00 down 14.54% with a 22-day hold time, and BTDR at USD 6.06 up 14.12% with a 17-day hold time and strong buy-side order activity at 96%.
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...
At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...
Ipsen Pharma has disclosed the total number of shares and voting rights composing its capital as of October 31, 2026. The company reported 83,814,526 shares and a gross total of 132,059,377 voting rights, with a net total of 130,677,690 after excludi...
